Co-infection and Cancer (R21 Clinical Trial Not Allowed) (344904)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant

Next deadline: May 16, 2023 (Letter of inquiry)

Later deadlines: Jun 16, 2023 (Full proposal), Jun 16, 2023 (Letter of inquiry), Jul 16, 2023 (Full proposal), Oct 16, 2023 (Letter of inquiry), Nov 16, 2023 (Full proposal), Jan 16, 2024 (Letter of inquiry), Feb 14, 2024 (Letter of inquiry), Feb 16, 2024 (Full proposal), Mar 16, 2024 (Full proposal), May 16, 2024 (Letter of inquiry), Jun 16, 2024 (Full proposal), Jun 16, 2024, Jul 16, 2024 (Full proposal), Sep 16, 2024 (Letter of inquiry), Oct 16, 2024 (Full proposal), Oct 16, 2024 (Letter of inquiry), Nov 16, 2024 (Full proposal), Jan 16, 2025 (Letter of inquiry), Feb 14, 2025 (Letter of inquiry), Feb 16, 2025 (Full proposal), Mar 16, 2025 (Full proposal), May 16, 2025 (Letter of inquiry), Jun 16, 2025 (Full proposal), Jun 16, 2025 (Letter of inquiry), Jul 16, 2025 (Full proposal), Sep 16, 2025 (Letter of inquiry), Oct 16, 2025 (Full proposal), Oct 16, 2025 (Letter of inquiry), Nov 16, 2025 (Full proposal)

Grant amount: Up to US $275,000

Fields of work: Cancer/Oncology

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: The following deadlines apply to standard grant applications (due by 5:00 pm  local time of applicant organization):

  • February 16, 2023
  • June 16, 2023
  • October 16, 2023
  • February 16, 2024
  • June 16, 2024
  • October 16, 2024
  • February 16, 2025
  • June 16, 2025
  • October 16, 2025

Deadlines for AIDS-related projects are the following (due by 5:00 pm local time of applicant organization):

  • March 16, 2023 
  • July 16, 2023
  • November 16, 2023
  • March 16, 2024
  • July 16, 2024
  • November 16, 2024
  • March 16, 2025
  • July  16, 2025
  • November 16, 2025

The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection and cancer to shed light on presently unestablished pathways in carcinogenesis that may inform prevention and treatment strategies for infection-related cancers. Co-infection is defined as the occurrence of infections by two or more infectious (pathogenic or non-pathogenic) agents either concurrently or sequentially and includes both acute and chronic infections by viruses, bacteria, parasites, and/or other microorganisms. Preference will be given to investigations of co-infections with known oncogenic agents (excluding human immunodeficiency virus [HIV]) and of co-infections that engender novel opportunities for prevention and treatment.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed December 17, 2022 and last updated December 17, 2022